These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30352219)

  • 1. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
    Mao L; Le S; Jin X; Liu G; Chen J; Hu J
    Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
    Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
    Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
    Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
    J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
    Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
    Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
    Ma Y; Xia P; Wang Z; Xu J; Zhang L; Jiang Y
    Neoplasia; 2021 Sep; 23(9):912-928. PubMed ID: 34325342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2.
    Zhu X; Yu M; Wang K; Zou W; Zhu L
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):294-301. PubMed ID: 32152631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
    Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
    Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.
    Li J; Li Y; Wang B; Ma Y; Chen P
    Biochem Biophys Res Commun; 2018 Jun; 500(2):132-138. PubMed ID: 29596838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
    Huang M; Xiong H; Luo D; Xu B; Liu H
    Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation.
    Zhang S; Hong Z; Chai Y; Liu Z; Du Y; Li Q; Liu Q
    Biochem Biophys Res Commun; 2017 Jun; 488(1):101-108. PubMed ID: 28479251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
    Zhong G; Li H; Shan T; Zhang N
    Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis.
    Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M
    Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
    Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
    Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
    Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
    J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
    Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
    Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.
    Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH
    Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
    Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
    Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
    Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
    Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.